Raymond James Financial
QNRX

Raymond James Financial’s Quoin Pharmaceuticals QNRX Stock Holding History

Raymond James Financial’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-717
Closed -$6.62K – 6335
2025
Q2 		$6.62K Sell
717
-1
-0.1% -$8 ﹤0.01% 6075
2025
Q1 		$5.62K Hold
718
– – ﹤0.01% 4795
2024
Q4 		$16.3K Buy
+718
New +$16.5K ﹤0.01% 4745

Other funds holding QNRX

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raymond James Financial's QNRX Position: Q3 2025 in Review

Raymond James Financial sold out of Quoin Pharmaceuticals (QNRX) in Q3 2025, closing a stake of 717 shares — an estimated $6.62K sold.

Raymond James Financial first reported a position in QNRX in Q4 2024 and held it in 3 quarters. The position peaked at $16.3K in Q4 2024. 5 funds tracked by Wall St. Rank hold QNRX as of Q3 2025.

  • Raymond James Financial reported no remaining Quoin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 717 Quoin Pharmaceuticals shares in Q3 2025, an estimated $6.62K.
  • Raymond James Financial first reported a position in Quoin Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Quoin Pharmaceuticals position peaked at $16.3K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.